TY - JOUR
T1 - Risks and benefits of Twitter use by hematologists/oncologists in the era of digital medicine
AU - for the Collaboration for Outcomes on Social Media in Oncology (COSMO)
AU - Attai, Deanna J.
AU - Anderson, Patricia F.
AU - Fisch, Michael J.
AU - Graham, David L.
AU - Katz, Matthew S.
AU - Kesselheim, Jennifer
AU - Markham, Merry Jennifer
AU - Pennell, Nathan A.
AU - Sedrak, Mina S.
AU - Thompson, Michael A.
AU - Utengen, Audun
AU - Dizon, Don S.
N1 - Publisher Copyright:
© 2017 Elsevier Inc.
PY - 2017/10
Y1 - 2017/10
N2 - Twitter use by physicians, including those in the hematology–oncology field, is increasing. This microblogging platform provides a means to communicate and collaborate on a global scale. For the oncology professional, an active Twitter presence provides opportunities for continuing medical education, patient engagement and education, personal branding, and reputation management. However, because Twitter is an open, public forum, potential risks such as patient privacy violations, personal information disclosures, professionalism lapses, and time management need to be considered and managed. The authors have summarized the benefits and risks of Twitter use by the hematology–oncology physician. In addition, strategies to maximize benefit and minimize risk are discussed, and resources for additional learning are provided.
AB - Twitter use by physicians, including those in the hematology–oncology field, is increasing. This microblogging platform provides a means to communicate and collaborate on a global scale. For the oncology professional, an active Twitter presence provides opportunities for continuing medical education, patient engagement and education, personal branding, and reputation management. However, because Twitter is an open, public forum, potential risks such as patient privacy violations, personal information disclosures, professionalism lapses, and time management need to be considered and managed. The authors have summarized the benefits and risks of Twitter use by the hematology–oncology physician. In addition, strategies to maximize benefit and minimize risk are discussed, and resources for additional learning are provided.
KW - Digital engagement
KW - Health information
KW - Hematologist–Oncologist
KW - Patient education
KW - Social media
KW - Twitter
UR - http://www.scopus.com/inward/record.url?scp=85028450307&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85028450307&partnerID=8YFLogxK
U2 - 10.1053/j.seminhematol.2017.08.001
DO - 10.1053/j.seminhematol.2017.08.001
M3 - Review article
C2 - 29153081
AN - SCOPUS:85028450307
SN - 0037-1963
VL - 54
SP - 198
EP - 204
JO - Seminars in hematology
JF - Seminars in hematology
IS - 4
ER -